Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Hepatitis B Surface Antigens/blood"'
Publikováno v:
Bulletin of the World Health Organization, Vol 80, Iss 4, Pp 277-281 (2002)
OBJETIVE: To evaluate the effectiveness of universal vaccination against viral hepatitis B in South Africa among 18-month-old rural children. METHODS: Children were immunized with a course of low-dose (1.5 mug), plasma-derived hepatitis B vaccine at
Externí odkaz:
https://doaj.org/article/b43554d0126a4594813ea30146427d83
Autor:
Jeanne Heil, Jochen W L Cals, Inge H.M. van Loo, Nicole H. T. M. Dukers-Muijrers, Christian J. P. A. Hoebe, Henriëtte L G Ter Waarbeek
Publikováno v:
Annals of Family Medicine, 16(1), 21-27. Annals of Family Medicine, Inc
PURPOSE Both chronic hepatitis C (HCV) and B virus (HBV) infections are generally asymptomatic, and many remain undetected or are diagnosed at a late stage. Studies that evaluate best practice hepatitis testing strategies are needed to better detect
Autor:
Pierre Gantner, Laurent Cotte, Clotilde Allavena, Firouzé Bani-Sadr, Thomas Huleux, Claudine Duvivier, Marc-Antoine Valantin, Christine Jacomet, Véronique Joly, Antoine Chéret, Pascal Pugliese, Pierre Delobel, André Cabié, David Rey, Dat’AIDS Study Group
Publikováno v:
PLoS ONE
PLoS ONE, 2019, 14 (4), pp.e0215464. ⟨10.1371/journal.pone.0215464⟩
PLoS ONE, Public Library of Science, 2019, 14 (4), pp.e0215464. ⟨10.1371/journal.pone.0215464⟩
PLoS ONE, Vol 14, Iss 4, p e0215464 (2019)
PLoS ONE, 2019, 14 (4), pp.e0215464. ⟨10.1371/journal.pone.0215464⟩
PLoS ONE, Public Library of Science, 2019, 14 (4), pp.e0215464. ⟨10.1371/journal.pone.0215464⟩
PLoS ONE, Vol 14, Iss 4, p e0215464 (2019)
IntroductionAchieving functional cure of chronic HBV infection (Hepatitis B surface antigen [HBsAg] clearance, eventually followed by acquisition of anti-hepatitis B surface antigen [Anti-HBs]) in individuals with HIV and HBV infections is a rare eve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2c879522156128d87ef13694d8d2319
https://hal.sorbonne-universite.fr/hal-02110275
https://hal.sorbonne-universite.fr/hal-02110275
Publikováno v:
BMC INFECTIOUS DISEASES
Stockdale, A J, Mitambo, C, Everett, D, Geretti, A M & Gordon, M A 2018, ' Epidemiology of hepatitis B, C and D in Malawi : systematic review ', BMC Infectious Diseases, vol. 18, no. 1, pp. 516 . https://doi.org/10.1186/s12879-018-3428-7
BMC Infectious Diseases
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-10 (2018)
Stockdale, A J, Mitambo, C, Everett, D, Geretti, A M & Gordon, M A 2018, ' Epidemiology of hepatitis B, C and D in Malawi : systematic review ', BMC Infectious Diseases, vol. 18, no. 1, pp. 516 . https://doi.org/10.1186/s12879-018-3428-7
BMC Infectious Diseases
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-10 (2018)
Background Viral hepatitis is an important public health issue in sub-Saharan Africa. Due to rising mortality from cirrhosis and hepatocellular carcinoma and limited implementation of screening and treatment programmes, it has been characterised as a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::961f878bb50220fb4e41a3f728abc799
Publikováno v:
Liječnički vjesnik
Volume 139
Issue 1-2
Volume 139
Issue 1-2
Idealni cilj antivirusne terapije ili izlječenje kroničnog hepatitisa B jesu gubitak HBsAg i HBsAg-serokonverzija. Prema suvremenim smjernicama svih udruga za bolesti jetre, pegilirani interferon alfa-2a i nukleoz(t)idni analozi (entekavir, tenofov
Autor:
Mei Hsuan Lee, Maurizia Rossana Brunetto, Stefan Mauss, Sabahattin Kaymakoglu, CE Omuemu, Danjuma Adda, Philip Bruggmann, Beat Müllhaupt, Trân D Quang, Peter Jarcuska, Man-Fung Yuen, George V. Papatheodoridis, Rohani Jahis, Ding-Shinn Chen, Necati Örmeci, Christophe Moreno, Angelos Hatzakis, Antoine Abou Rached, Boris Lukšić, Thomas Berg, Renovat Ntagirabiri, Kathryn Razavi-Shearer, Sarah Blach, Gabriela Rjaskova, Samantha M Brandon, Jen Layden, Ohene Opare-Sem, Maria C Mendes Correa, Stefano Vella, Jan Sperl, Vincent Wai-Sun Wong, Hwai I. Yang, Stephen Oguche, Richard Njouom, Cielo Yaneth Rios, Yee Tak Hui, Behzad Hajarizadeh, Andy I. M. Hoepelman, Javier García-Samaniego, Ammal M. Metwally, Ivane Gamkrelidze, Julia A. Scott, Said A. Al-Busafi, Valentina Liakina, Zaigham Abbas, Olga Sagalova, Rifaat Safadi, Michael Manns, William Sievert, Seyed M Alavian, Kakharman Yesmembetov, Manal H El-Sayed, Juan Francisco Sánchez-Ávila, Wan-Long Chuang, Peter Stärkel, Ziv Ben-Ari, Chris Cunningham, Homie Razavi, Erkin Musabaev, Ulus Salih Akarca, Petr Urbánek, Gamal Shiha, Muhammed Aasim M Yusuf, Nina Weis, Hossein Poustchi, Ilias Gountas, E. A. Croes, Ayman Yosry, Reza Malekzadeh, Kostas Athanasakis, Agustín Albillos, Faleh Z. Al-Faleh, Christoph Sarrazin, Maria Buti, Arif Nawaz, Chung-Lin Yang, Kimberly Murphy, Adriana Vince, Aliya Konysbekova, Soek Siam Tan, Loreta A. Kondili, Mojca Matičič, Karolin Falconer, Hailemichael Desalegn, Alexander Nersesov, Ogu Omede, N. N. Pimenov, Nahum Méndez-Sánchez, Benjamin C Cowie, Helen Nde, Wai-cheung C Lao, Jordan Genov, Imam Waked, Joël Mossong, Ala I. Sharara, Henry Lik-Yuen Chan, Vivek A. Saraswat, Diego Alberto Cuellar, Devin Razavi-Shearer, Abraham O. Malu, Rui Tato Marinho, Huma Qureshi, Markus Cornberg, Faisal M. Sanai, Ching-kong K Loo, David Kershenobich, Pavol Kristian, Paulo R. Ferreira, Mel Krajden, Moon Seok Choi, Junko Tanaka, Faryal Al Lawati, Jonathan Schmelzer, Ann-Sofi Duberg, Jan Gerstoft, Lewis R. Roberts, Francesco Negro, Khalid Al Naamani, Wim Laleman, Solomon Obekpa, Henk W. Reesink, Tesia Shin, Richard Gray, Alnoor Ramji, Fadi H. Mourad, Abdul Rahman Bizri, Joop E. Arends, Shahin Merat, Krzysztof Tomasiewicz, Adkhamjon Mamatkulov, Jerzy Jaroszewicz, Peer Brehm Christensen, Adriaan J. van der Meer, Maheeba Abdulla, Frank Tacke, Cesar Yaghi, Pierre Van Damme, Christopher K Opio, Yasir Waheed, Joseph Woodring, Ponsiano Ocama, Zuridin Nurmatov, Bisi Bright, Van Thi Thuy Nguyen, Perttu Arkkila, Nick Walsh, Catherine A.M. Stedman, Mette Rye Clausen, Vladimir Chulanov, Antonio Craxì, Christophe Hézode, Abdulrahman Aljumah, Jeffrey V. Lazarus, Fuad Hasan, Sarah Robbins, Sona Frankova, Adrian Goldis, Rong-Nan Chien, Chris Estes, Stephen D. Ryder, Nguyen Thu Anh, Abate Bane, Muhammad S. Memon, Ken Pasini, Ivan Schréter, Sameer Alawadhi, Stuart K. Roberts, Steve S Egeonu, Anil C. Anand, Riina Salupere, Massimo Colombo, Giovanni Battista Gaeta, Maria Lucia Gomes Ferraz, Rosmawati Mohamed, Sylvia Drazilova, Hans Van Vlierberghe, Soo Aleman, Naveed Z. Janjua, Irena Hrstić, Manik Sharma, Carlos E Brandão Mello, Mario G. Pessoa, Berhane Redae, Mindie H. Nguyen, Petr Husa, Vana Sypsa, Samir Shah, Jacques E Mokhbat, Robert Flisiak, Carole Seguin-Devaux, Asad Chaudhry, Inka Aho, Sayed Himatt, Hamad I. Al-Ashgar, Young-Suk Lim, Stefan Zeuzem
Publikováno v:
LANCET GASTROENTEROLOGY & HEPATOLOGY
lancet. Gastroenterology & hepatology, 3(6), 383-403. Elsevier Limited
Lancet Gastroenterology & Hepatology, 3(6), 383-403. Elsevier Ltd.
The Lancet Gastroenterology & Hepatology, Vol. 3, No 6 (2018) pp. 383-403
The Polaris Observatory Collaborators & Christensen, P B 2018, ' Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016 : a modelling study ', The Lancet Gastroenterology & Hepatology, vol. 3, no. 6, pp. 383-403 . https://doi.org/10.1016/S2468-1253(18)30056-6
The Lancet Gastroenterology & Hepatology
Volume 3
Issue 6
lancet. Gastroenterology & hepatology, 3(6), 383-403. Elsevier Limited
Lancet Gastroenterology & Hepatology, 3(6), 383-403. Elsevier Ltd.
The Lancet Gastroenterology & Hepatology, Vol. 3, No 6 (2018) pp. 383-403
The Polaris Observatory Collaborators & Christensen, P B 2018, ' Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016 : a modelling study ', The Lancet Gastroenterology & Hepatology, vol. 3, no. 6, pp. 383-403 . https://doi.org/10.1016/S2468-1253(18)30056-6
The Lancet Gastroenterology & Hepatology
Volume 3
Issue 6
PubMed: 29599078
2-s2.0-85044540918
Background: The 69th World Health Assembly approved the Global Health Sector Strategy to eliminate viral hepatitis by 2030. Although no virological cure exists for hepatitis B virus (HBV) infection, exist
2-s2.0-85044540918
Background: The 69th World Health Assembly approved the Global Health Sector Strategy to eliminate viral hepatitis by 2030. Although no virological cure exists for hepatitis B virus (HBV) infection, exist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bb7ea4b92043218a2fb98bdb3797f64
https://doi.org/10.5167/uzh-160950
https://doi.org/10.5167/uzh-160950
Autor:
Roland Sahli, Enos Bernasconi, Dominique L Braun, Huldrych F. Günthard, Franziska Suter-Riniker, Gilles Wandeler, Charles Béguelin, Manuel Battegay, Matthias Cavassini, Darius Moradpour, Alexandra Calmy, Alexander Lüthi, Andri Rauch, Hansjakob Furrer, Patrick Schmid
Publikováno v:
Journal of Hepatology, Vol. 66, No 2 (2017) pp. 297-303
Background & Aims Hepatitis delta virus (HDV) infection accelerates the progression of hepatitis B virus (HBV)-related liver disease. We assessed the epidemiological characteristics of HDV infection in the nationwide Swiss HIV Cohort Study and evalua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b668d1d715d2a1525053c5c646d1cd90
https://www.zora.uzh.ch/id/eprint/126818/
https://www.zora.uzh.ch/id/eprint/126818/
Autor:
Harr Freeya Njai, Ramou Njie, Gibril Ndow, Aboubacar Kambi, Maimuna Mendy, Isabelle Chemin, Tumani Corrah, Saydiba Tamba, Maud Lemoine, Adam Jeng, Louise Sarr, Souleymane Mboup, Shevanthi Nayagam, Mark Thursz, Hilton Whittle, Jessica Howell, Penda Suso, Makie Taal, Amina Sow, Liliane Mpabanzi, Simon D. Taylor-Robinson, Yusuke Shimakawa, Ousman Nyan, William Stanger, Coumba Toure-Kane, Saunab Ghosh, Abdullah Jatta, Umberto D'Alessandro
Publikováno v:
The Lancet global health
The Lancet global health, Elsevier, 2016, 4 (8), pp.e559-e567. ⟨10.1016/S2214-109X(16)30130-9⟩
The Lancet Global Health, Vol 4, Iss 8, Pp e559-e567 (2016)
The Lancet global health, 2016, 4 (8), pp.e559-e567. ⟨10.1016/S2214-109X(16)30130-9⟩
e567
e559
The Lancet global health, Elsevier, 2016, 4 (8), pp.e559-e567. ⟨10.1016/S2214-109X(16)30130-9⟩
The Lancet Global Health, Vol 4, Iss 8, Pp e559-e567 (2016)
The Lancet global health, 2016, 4 (8), pp.e559-e567. ⟨10.1016/S2214-109X(16)30130-9⟩
e567
e559
Comment in : Screen-and-treat for chronic hepatitis B: an overdue issue for sub-Saharan Africa./Allain JP. Lancet Glob Health. 2016 Aug;4(8):e507-8. doi: 10.1016/S2214-109X(16)30140-1. PMID: 27443770; International audience; Background: Despite the i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ce96b12b42eac91dfb0ac53ad6b8113
https://hal-pasteur.archives-ouvertes.fr/pasteur-02875279/file/1-s2.0-S2214109X16301309-main.pdf
https://hal-pasteur.archives-ouvertes.fr/pasteur-02875279/file/1-s2.0-S2214109X16301309-main.pdf
Autor:
Nayagam, Shevanthi, Conteh, Lesong, Sicuri, Elisa, Shimakawa, Yusuke, Suso, Penda, Tamba, Saydiba, Njie, Ramou, Njai, Harr, Lemoine, Maud, Hallett, Timothy B, Thursz, Mark
Publikováno v:
e578
e568
The Lancet global health
The Lancet global health, 2016, 4 (8), pp.e568-e578. ⟨10.1016/S2214-109X(16)30101-2⟩
Dipòsit Digital de la UB
Universidad de Barcelona
The Lancet global health, Elsevier, 2016, 4 (8), pp.e568-e578. ⟨10.1016/S2214-109X(16)30101-2⟩
Recercat. Dipósit de la Recerca de Catalunya
instname
e568
The Lancet global health
The Lancet global health, 2016, 4 (8), pp.e568-e578. ⟨10.1016/S2214-109X(16)30101-2⟩
Dipòsit Digital de la UB
Universidad de Barcelona
The Lancet global health, Elsevier, 2016, 4 (8), pp.e568-e578. ⟨10.1016/S2214-109X(16)30101-2⟩
Recercat. Dipósit de la Recerca de Catalunya
instname
Erratum in :Correction to Lancet Glob Health 2016; 4: e568-78.Lancet Glob Health. 2016 Nov;4(11):e794. doi: 10.1016/S2214-109X(16)30272-8. PMID: 27765292; International audience; Background: Despite the high burden of hepatitis B virus (HBV) infectio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::efd9503b46a7e7dcea2b456e20926a5c
http://hdl.handle.net/10044/1/33155
http://hdl.handle.net/10044/1/33155
Autor:
Ramou Njie, Robert D. Goldin, Umberto D'Alessandro, A. Jeng-Barry, Christian Bottomley, Makie Taal, Sophie E. Moore, Abdoulie Jatta, Mark Thursz, Maimuna Mendy, Hilton Whittle, Ignatius Baldeh, Rita Wegmüller, Maud Lemoine, Gibril Ndow, Yusuke Shimakawa, Harr Freeya Njai
Publikováno v:
Gut
Gut, 2016, 65 (12), pp.2007-2016. ⟨10.1136/gutjnl-2015-309892⟩
Gut, BMJ Publishing Group, 2016, 65 (12), pp.2007-2016. ⟨10.1136/gutjnl-2015-309892⟩
Gut, 2016, 65 (12), pp.2007-2016. ⟨10.1136/gutjnl-2015-309892⟩
Gut, BMJ Publishing Group, 2016, 65 (12), pp.2007-2016. ⟨10.1136/gutjnl-2015-309892⟩
International audience; Background: The natural history of chronic HBV infection in sub-Saharan Africa is unknown. Data are required to inform WHO guidelines that are currently based on studies in Europe and Asia.Methods: Between 1974 and 2008, seros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::316e6b8d42f66253217a5befe4eddba7
http://hdl.handle.net/10044/1/52191
http://hdl.handle.net/10044/1/52191